CAJ | 학술논문

目的：探讨CT引导下氩氦刀冷冻消融治疗腹部转移性肿瘤的近期临床疗效。方法选取9例确诊为腹部转移性肿瘤的患者，在CT引导下采用氩氦刀冷冻消融术治疗转移性病灶。结果9例患者均成功手术，病灶平均冰球覆盖率为（95.0±4.8）%，平均冷冻时间（22.4±7.6）min，平均复温时间（11.2±4.6）min，患者术后1个月和3个月临床受益率分别为100.0%和91.7%；术后并发症轻微，未见冷休克、肝破裂出血及肾功能不全等严重并发症。结论CT引导下氩氦刀冷冻消融治疗腹部转移性肿瘤安全有效，创伤微小，近期效果满意。
목적：탐토CT인도하아양도냉동소융치료복부전이성종류적근기림상료효。방법선취9례학진위복부전이성종류적환자，재CT인도하채용아양도냉동소융술치료전이성병조。결과9례환자균성공수술，병조평균빙구복개솔위（95.0±4.8）%，평균냉동시간（22.4±7.6）min，평균복온시간（11.2±4.6）min，환자술후1개월화3개월림상수익솔분별위100.0%화91.7%；술후병발증경미，미견랭휴극、간파렬출혈급신공능불전등엄중병발증。결론CT인도하아양도냉동소융치료복부전이성종류안전유효，창상미소，근기효과만의。
Objective To investigate the short-term clinical benefit of cryoablation for abdominal metastatic tumors under CT guidance. Methods A total of 9 patients with confirmed abdominal metastatic tumors received argon-helium cryoablation under CT guidance. Results All patients had successful cryotherapy with the average ice-ball coverage rate of (95.0± 4.8)%. The mean cryoablation time and rewarming time was (22.4±7.6) min and (11.2±4.6) min. The clinical benefit rates of 1 and 3 months after cryoablation were 100% and 91.7%, respectively. In addition,the complications after cryoablation were mild without severe ones such as cold shock, hepatic hemorrhage and renal insufficiency. Conclusion CT-guided argon-helium cryoablation for abdominal metastatic tumors is safe,effective and minimally invasive, with satisfying clinical benefit.